Q-omics provides the consensus-scored SNORA21 profile across patient tissues and cancer cell-line models. Additionally, SNORA21 RNA expression shows 1 significant drug associations, with the highest sampling consensus in PEMB_ALL.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORA21 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SNORA21 in patient tissues and cancer cell lines. In patient samples, SNORA21 shows the broadest associations at the RNA and protein expression levels, with PEMB_ALL recurring as the lineage with the largest associated feature set. In cancer cell lines, SNORA21 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in NCI60_ALL.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Drug	1	PEMB_ALL (1)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Inducing drug	3	NCI60_ALL (3)	view →